Effect of smoking on risperidone pharmacokinetics – A multifactorial approach to better predict the influence on drug metabolism

Schoretsanitis, Georgios; Haen, Ekkehard; Stegmann, Benedikt; Hiemke, Christoph; Gründer, Gerhard; Paulzen, Michael (2017). Effect of smoking on risperidone pharmacokinetics – A multifactorial approach to better predict the influence on drug metabolism. Schizophrenia Research, 185, pp. 51-57. Elsevier 10.1016/j.schres.2016.12.016

Text Schoretsanitis et al 2016.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (526kB)

Purpose
To disentangle an association between tobacco smoking, smoking habits and pharmacokinetic patterns such as plasma concentrations of risperidone (RIS), its active metabolite 9-hydroxyrisperidone (9-
OH-RIS) and the active moiety, AM, (RIS + 9-OH-RIS) in a naturalistic sample.
Methods
Plasma concentrations, dose adjusted plasma concentrations (C/D) of RIS, 9-OH-RIS and AM in patients out of a therapeutic drug monitoring (TDM) database were compared between smokers (n = 401) and non-smokers (n = 292).
Results
Daily dosage of risperidone differed significantly with smokers receiving higher doses than patients in the control group (p = 0.001). No differences were detected in plasma concentrations of the active
moiety, RIS and 9-OH-RIS (p = 0.8 for AM, p = 0.646 for RIS and p = 0.538 for 9-OH-RIS). However, dose corrected concentrations (C/D) of metabolite (C/D 9-OH-RIS) and active moiety (C/D AM) differed
between significantly between groups (p = 0.002 and p = 0.007). After stratifying smokers to a group of moderate smokers (< 20 cigarettes/day) (RS1, n = 109) and a group of heavy smokers
(≥ 20 cigarettes/day) (RS2, n = 135), the comparison between non-smokers and both groups only showed lower values of C/D for 9-OH-RIS (p = 0.011) for the group of moderate smokers while other
pharmacokinetic parameters did not differ.
Conclusions
Apart from the well-known induction of CYP1A2 activity by polycyclic aromatic hydrocarbons, smoking might exert an effect on other CYP isoenzymes as well. A possible interpretation proposes a slight
inducing effect of smoking on risperidone metabolism most likely via CYP3A4.

Interest & Impact

Downloads

2 since deposited on 12 Apr 2017
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item